PGR and ductal breast carcinoma in situ: In two previous studies, we found that human epidermal growth factor receptor 2 (HER2)-enriched high-grade DCIS was a high-risk subtype because it was strongly linked to having invasive components (8) and low progesterone receptor (PR) levels, correlated with HER2 overexpression and the presence of invasive components (9).